Two Sigma Securities »

Lyra Therapeutics shares owned by Two Sigma Securities

Quarter-by-quarter ownership of Lyra Therapeutics (LYRA) shares owned by Two Sigma Securities from 13F filings

Historical chart of Two Sigma Securities investment in Lyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lyra Therapeutics held by Two Sigma Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyra Therapeutics by Two Sigma Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $67k 13k 5.24
2022-09-30 $64k 13k 5.01

More positions owned by Two Sigma Securities

Apple (AAPL)
Microsoft Corporation Call Option (MSFT)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tesla Motors (TSLA)
Meta Platforms Cl A Call Option (META)
Amazon (AMZN)
Netflix (NFLX)
Advanced Micro Devices Call Option (AMD)
Boeing Company Call Option (BA)
Alphabet Cap Stk Cl A (GOOGL)
Visa Com Cl A (V)
Johnson & Johnson Call Option (JNJ)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Broadcom Call Option (AVGO)

View all positions for Two Sigma Securities

Top funds holding Lyra Therapeutics

Perceptive Advisors
Nantahala Capital Management
Point72 Asset Management
Citadel Advisors
Samsara BioCapital
VR Adviser
Ikarian Capital
Rosalind Advisors
Vanguard Group
Millennium Management
Alyeska Investment Group
Bank of America Corporation
Two Sigma Investments
Citigroup
Clearline Capital

View all funds holding Lyra Therapeutics